Scorpius Holdings Inc (SCPX)
0.735
+0.02
(+2.67%)
USD |
NYAM |
Nov 04, 16:00
0.75
+0.02
(+2.04%)
After-Hours: 20:00
Scorpius Holdings Enterprise Value: -0.2873M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -0.2873M |
| November 01, 2024 | -0.3468M |
| October 31, 2024 | -0.334M |
| October 30, 2024 | -0.2093M |
| October 29, 2024 | -0.4041M |
| October 28, 2024 | -0.3028M |
| October 25, 2024 | -0.334M |
| October 24, 2024 | -0.2343M |
| October 23, 2024 | -0.1782M |
| October 22, 2024 | -0.08M |
| October 21, 2024 | -0.0106M |
| October 18, 2024 | -0.0224M |
| October 17, 2024 | -0.1688M |
| October 16, 2024 | -0.295M |
| October 15, 2024 | -0.2405M |
| October 14, 2024 | -0.2405M |
| October 11, 2024 | -0.3013M |
| October 10, 2024 | -0.2455M |
| October 09, 2024 | -0.2452M |
| October 08, 2024 | -0.2405M |
| October 07, 2024 | -0.1944M |
| October 04, 2024 | -0.2873M |
| October 03, 2024 | -0.2997M |
| October 02, 2024 | -0.2218M |
| October 01, 2024 | -0.2935M |
| Date | Value |
|---|---|
| September 30, 2024 | -0.334M |
| September 27, 2024 | -0.3028M |
| September 26, 2024 | -0.3926M |
| September 25, 2024 | -0.2717M |
| September 24, 2024 | -0.2333M |
| September 23, 2024 | -0.1451M |
| September 20, 2024 | -0.0626M |
| September 19, 2024 | 0.0992M |
| September 18, 2024 | -0.0654M |
| September 17, 2024 | -0.1236M |
| September 16, 2024 | 0.0867M |
| September 13, 2024 | -0.0361M |
| September 12, 2024 | 0.0088M |
| September 11, 2024 | 0.0571M |
| September 10, 2024 | 0.0711M |
| September 09, 2024 | 0.0674M |
| September 06, 2024 | 0.0555M |
| September 05, 2024 | 0.0088M |
| September 04, 2024 | 0.2114M |
| September 03, 2024 | 0.2269M |
| August 30, 2024 | 0.1911M |
| August 29, 2024 | 0.1169M |
| August 28, 2024 | -0.0096M |
| August 27, 2024 | -0.0844M |
| August 26, 2024 | -0.0573M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-43.61M
Minimum
Mar 15 2022
381.70M
Maximum
Jul 20 2020
16.41M
Average
0.4878M
Median
Jan 02 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.875M |
| Revenue (Quarterly) | 0.7599M |
| Total Expenses (Quarterly) | 9.458M |
| EPS Diluted (Quarterly) | -26.98 |
| Gross Profit Margin (Quarterly) | -10.26% |
| Profit Margin (Quarterly) | -1.17K% |
| Earnings Yield | -27.34K% |
| Normalized Earnings Yield | -25959.49 |